{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:21:31Z","timestamp":1792693291957,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11604-023-01386-2","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:51:10Z","timestamp":1673934670000},"page":"660-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patterns of failure in glioblastoma multiforme following Standard (60\u00a0Gy) or Short course (40\u00a0Gy) radiation and concurrent temozolomide"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-1643","authenticated-orcid":false,"given":"Miu","family":"Mizuhata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Minamikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Kumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Gabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"suppl_5","key":"1386_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013. Neuro Oncol. 2016;18(suppl_5):v1\u201375.","journal-title":"Neuro Oncol."},{"key":"1386_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"1386_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459\u201366.","journal-title":"Lancet Oncol"},{"key":"1386_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1215\/S1152851703000620","volume":"6","author":"KR Lamborn","year":"2004","unstructured":"Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6:227\u201335.","journal-title":"Neuro Oncol"},{"key":"1386_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","volume":"22","author":"W Roa","year":"2004","unstructured":"Roa W, Brasher PMA, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22:1583\u20138.","journal-title":"J Clin Oncol"},{"key":"1386_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2014.09.013","volume":"91","author":"G Minniti","year":"2015","unstructured":"Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V, Arcella A, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys. 2015;91:109\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1386_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.02.013","volume":"86","author":"G Minniti","year":"2013","unstructured":"Minniti G, Scaringi C, Baldoni A, Lanzetta G, De Sanctis V, Esposito V, et al. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys. 2013;86:285\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1386_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ, Brandes AA, Menten J, Phillips C, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 2017;376:1027\u201337.","journal-title":"N Engl J Med"},{"key":"1386_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2176\/nmc.52.577","volume":"52","author":"Y Konishi","year":"2012","unstructured":"Konishi Y, Muragaki Y, Iseki H, Mitsuhashi N, Okada Y. Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases. Neurol Med Chir (Tokyo). 2012;52:577\u201386.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1386_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","volume":"111","author":"K Petrecca","year":"2013","unstructured":"Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol. 2013;111:19\u201323.","journal-title":"J Neurooncol"},{"key":"1386_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2009.10.048","volume":"79","author":"MW McDonald","year":"2011","unstructured":"McDonald MW, Shu HKG, Curran WJ Jr, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiol Oncol Biol Phys. 2011;79:130\u20136.","journal-title":"Int J Radiol Oncol Biol Phys"},{"key":"1386_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.radonc.2017.01.002","volume":"122","author":"M Lundemann","year":"2017","unstructured":"Lundemann M, Costa JC, Law I, Engellholm SA, Muhic A, Poulsen HS, et al. Patterns of failure for patients with glioblastoma following O-(2-[18F]fluoroethyl)-L-tyrosine PET- and MRI-guided radiotherapy. Radiother Oncol. 2017;122:380\u20136.","journal-title":"Radiother Oncol"},{"key":"1386_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1748-717X-9-130","volume":"9","author":"BJ Gebhardt","year":"2014","unstructured":"Gebhardt BJ, Dobelbower MC, Ennis WH, Bag AK, Markert JM, Fiveash JB. Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide. Radiat Oncol. 2014;9:130.","journal-title":"Radiat Oncol"},{"key":"1386_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11604-011-0031-x","volume":"30","author":"R Murakami","year":"2012","unstructured":"Murakami R, Hirai T, Nakamura H, Furusawa M, Nakaguchi Y, Uetani H, et al. Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval. Jpn J Radiol. 2012;30:193\u20137.","journal-title":"Jpn J Radiol"},{"key":"1386_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11060-019-03152-9","volume":"143","author":"TJ Kruser","year":"2019","unstructured":"Kruser TJ, Bosch WR, Badiyan SN, Bovi JA, Ghia AJ, Kim MM, et al. NRG brain tumor specialists consensus guidelines for glioblastoma contouring. J Neurooncol. 2019;143:157\u201366.","journal-title":"J Neurooncol"},{"key":"1386_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1227\/NEU.0b013e318223f5a7","volume":"70","author":"MA Vogelbaum","year":"2012","unstructured":"Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, et al. Application of novel response\/progression measures for surgically delivered therapies for gliomas: response assessment in neuro-oncology (RANO) working group. Neurosurgery. 2012;70:234\u201343.","journal-title":"Neurosurgery"},{"key":"1386_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527\u201335.","journal-title":"N Engl J Med"},{"key":"1386_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13:916\u201326.","journal-title":"Lancet Oncol"},{"key":"1386_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7812\/TPP\/14-083","volume":"19","author":"CN Chang-Halpenny","year":"2015","unstructured":"Chang-Halpenny CN, Yeh J, Lien WW. Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard-versus abbreviated-course radiotherapy. Perm J. 2015;19:15\u201320.","journal-title":"Perm J"},{"key":"1386_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-015-1923-x","volume":"125","author":"G Lombardi","year":"2015","unstructured":"Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri E, et al. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology). J Neurooncol. 2015;125:359\u201367.","journal-title":"J Neurooncol"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.prro.2015.12.001","volume":"6","author":"TJC Wang","year":"2016","unstructured":"Wang TJC, Wu CC, Jani A, Estrada J, Ung T, Chow DS, et al. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma. Pract Radiat Oncol. 2016;6:306\u201314.","journal-title":"Pract Radiat Oncol"},{"key":"1386_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ijrobp.2014.07.027","volume":"90","author":"S Adeberg","year":"2014","unstructured":"Adeberg S, K\u00f6nig L, Bostel T, Harrabi S, Welzel T, Debus J, et al. Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone. Int J Radiat Oncol Biol Phys. 2014;90:886\u2013993.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1386_CR23","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41598-018-22697-9","volume":"8","author":"S Bette","year":"2018","unstructured":"Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, et al. Retrospective analysis of radiological recurrence patterns in glioblastoma, their prognostic value and association to postoperative infarct volume. Sci Rep. 2018;8:4561.","journal-title":"Sci Rep"},{"key":"1386_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jnci.2016.07.001","volume":"28","author":"S Mallick","year":"2016","unstructured":"Mallick S, Benson R, Hakim A, Rath GK. Management of glioblastoma after recurrence: a changing paradigm. J Egypt Natl Canc Inst. 2016;28:199\u2013210.","journal-title":"J Egypt Natl Canc Inst"},{"key":"1386_CR25","first-page":"vdab067","volume":"3","author":"S Kawabata","year":"2021","unstructured":"Kawabata S, Suzuki M, Hirose K, Tanaka H, Kato T, Goto H, et al. Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study. Neurooncol Adv. 2021;3:vdab067.","journal-title":"Neurooncol Adv"},{"key":"1386_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49:694\u20139.","journal-title":"J Nucl Med"},{"key":"1386_CR27","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904\u201311.","journal-title":"J Nucl Med"},{"key":"1386_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response assessment in neuro-oncology working group and european association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:119\u2013208.","journal-title":"Neuro Oncol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-023-01386-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T17:05:59Z","timestamp":1685552759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-023-01386-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s11604-023-01386-2","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for this study was waived because of its retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}